Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131778) titled 'Correlation of FGFR2 Protein Expression, Molecular Profiling Features and Pathological Subtyping in Biliary Tract Carcinoma and Its Clinical Significance' on Sept. 6.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Linyi People's Hospital

Condition: Gallbladder cancer and bile duct cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Observation group of gallbladder cancer and bile duct cancer:50;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341603

Published by HT...